Notable Labs Ltd. Stock Analysis NTBLQ
Notable Labs Ltd. is a clinical-stage platform therapeutics company that develops predictive medicines for patients with cancer. The company is headquartered in Foster City, California and currently employs 16 full-time employees. The company went IPO on 2014-09-30. The firm has created a pipeline of therapeutics that address cancer and immune-inflammatory diseases with the goal of significantly improving patient outcomes and overcoming the limitations of approved treatments. The firm's product candidates are built off of two platform technologies: Vascular Targeting System (VTS), a gene-based technology targeting newly formed blood vessels, and Monocyte Targeting Technology (MTT), an antibody-based technology able to specifically inhibit monocyte migration for immune-inflammatory applications.
Read More Notable Labs Ltd (NTBLQ) Chart
Financial Metrics & Statements of Notable Labs Ltd (NTBLQ)
FAQ's for Notable Labs Ltd (NTBLQ)
- According to Musaffa’s Shariah screening methodology, Notable Labs Ltd (NTBLQ) is currently classified as NOT COVERED as of May 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.